NCT02648997
An Open-Label Phase II Study of Nivolumab in Adult Participants With Progessive/ Recurrent Meningioma treatment 2 recruiting NCT00517959
SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors No drug interventions treatment 3 unknown_status NCT02939833
Effects of Scalp Nerve Blocks on Systemic Inflammation No drug interventions treatment Not Available unknown_status NCT01880749
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas other 0 completed NCT06466720
Measuring and Mapping Cognitive Decline After Brain Radiosurgery No drug interventions Not Available Not Available not_yet_recruiting NCT01655927
Efficacy of Tranexamic Acid in Brain Tumor Resections treatment 3 unknown_status NCT05093751
Automated Segmentation and Volumetry for Meningioma Using Deep Learning No drug interventions Not Available Not Available completed NCT04374305
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) treatment 2 recruiting NCT05254197
SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) No drug interventions Not Available Not Available recruiting NCT00004483
NF2 Natural History Consortium No drug interventions Not Available Not Available unknown_status NCT00003483
Antineoplaston Therapy in Treating Patients With Meningioma treatment 2 terminated NCT03971461
Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma treatment 2 active_not_recruiting NCT06377371
Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE No drug interventions treatment 4 not_yet_recruiting NCT04638478
PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI No drug interventions Not Available Not Available recruiting NCT06126588
Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial treatment 2 not_yet_recruiting NCT02162732
Molecular-Guided Therapy for Childhood Cancer No drug interventions treatment Not Available completed NCT04386642
Tranexamic Acid Reduce Blood Loss in Meningioma Resection treatment 4 unknown_status NCT06036706
Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma: No drug interventions treatment Not Available recruiting NCT03001349
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors diagnostic 0 terminated NCT03267836
Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma treatment 1 terminated NCT02933736
Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients treatment 0 active_not_recruiting NCT00985036
Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients No drug interventions Not Available Not Available withdrawn NCT04298541
Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC diagnostic 2 not_yet_recruiting NCT04997317
Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide treatment 0 recruiting NCT03648034
Effects of Scalp Nerve Block With Ropivacaine on Postoperative Recovery Quality No drug interventions supportive_care Not Available completed NCT06104930
Plasma Extracellular Vesicles in Meningioma Patients No drug interventions basic_science Not Available recruiting NCT03095248
Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors treatment 2 suspended NCT03936426
Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ treatment 1 / 2 completed NCT06439420
CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial No drug interventions treatment 2 recruiting NCT06012929
A Study of ONC201 for Refractory Meningioma treatment 2 not_yet_recruiting NCT06460467
Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry No drug interventions Not Available Not Available not_yet_recruiting NCT03015701
S9005 Mifepristone in Meningioma treatment 3 completed NCT04081701
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. No drug interventions diagnostic 4 recruiting NCT05425004
Cabozantinib for Patients With Recurrent or Progressive Meningioma treatment 2 recruiting NCT04109404
Meningiomas and Treatment With CYPROTERONE ACETATE or Progestin No drug interventions Not Available Not Available completed NCT04189172
MiDura-Study (Neuro-Patch in Duraplasty) No drug interventions Not Available Not Available recruiting NCT04079595
Closed vs. Open Face Masks for Cranial Radiotherapy No drug interventions other Not Available completed NCT04113395
Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium No drug interventions Not Available Not Available recruiting NCT04372095
Androcur® (Cyproterone Acetate) and Meningioma Development: a Genotype-environment Association Study No drug interventions Not Available Not Available recruiting NCT04712214
Use of Non-invasive Optical Analysis in Neurosurgery No drug interventions other Not Available recruiting NCT01967823
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer treatment 2 completed NCT05576103
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients No drug interventions Not Available Not Available recruiting NCT02693990
A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas No drug interventions treatment Not Available recruiting NCT01166321
Carbon Ion Radiotherapy for Atypical Meningiomas No drug interventions treatment Not Available active_not_recruiting NCT03013387
Dosimetry Guided PRRT With 90Y-DOTATOC treatment 2 withdrawn NCT03631953
Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas treatment 1 recruiting NCT04478877
Establishment and Characterization of Meningioma Patient-derived Organoids No drug interventions Not Available Not Available completed NCT02978677
Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas No drug interventions treatment Not Available not_yet_recruiting NCT05139277
Evaluation of the CONVIVO System No drug interventions diagnostic Not Available recruiting NCT06014905
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma No drug interventions diagnostic 1 recruiting NCT05727605
Neurocognition After Radiotherapy in CNS- and Skull-base Tumors No drug interventions diagnostic Not Available recruiting NCT03583528
DOTATOC PET/CT for Imaging NET Patients No drug interventions Not Available Not Available recruiting NCT02267928
Information Presentation Formats No drug interventions screening Not Available completed NCT05940493
Abemaciclib in Newly Diagnosed Meningioma Patients treatment 2 not_yet_recruiting NCT01347307
Stereotactic Body Radiotherapy for Spine Tumors No drug interventions treatment Not Available completed NCT03702309
Liquid Biopsy Evaluation and Repository Development at Princess Margaret No drug interventions Not Available Not Available recruiting NCT06132685
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial treatment 2 not_yet_recruiting NCT05028400
Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery No drug interventions treatment Not Available completed NCT04305470
Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma diagnostic 3 completed NCT06255249
Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide No drug interventions Not Available Not Available not_yet_recruiting NCT02282917
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma treatment 0 terminated NCT05793034
Predictive Factors for Survival in Aggressive Meningiomas No drug interventions diagnostic Not Available recruiting NCT01811524
The Etiology and Progression of Brain Tumors No drug interventions Not Available Not Available completed NCT03558516
Magnesium and Intraoperative Blood Loss in Meningioma Surgery No drug interventions other 3 completed NCT04595786
The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection treatment Not Available active_not_recruiting NCT02831257
AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas treatment 2 completed NCT04635657
Cognitive Status After Removal of Skull Base Meningioma No drug interventions Not Available Not Available recruiting NCT06180226
Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH Adenomas No drug interventions Not Available Not Available completed NCT03071874
Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas treatment 2 active_not_recruiting NCT03953131
Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas No drug interventions diagnostic 1 completed NCT04648462
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology No drug interventions Not Available Not Available recruiting NCT01117844
Proton Radiation For Meningiomas and Hemangiopericytomas No drug interventions treatment 1 / 2 active_not_recruiting NCT00859040
Monthly SOM230C for Recurrent or Progressive Meningioma treatment 2 completed NCT05416567
Embolization for Meningioma No drug interventions treatment Not Available recruiting NCT03273712
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) treatment 2 completed NCT06557512
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma No drug interventions treatment Not Available not_yet_recruiting NCT00706810
Combination of Hydroxyurea and Verapamil for Refractory Meningiomas treatment 2 completed NCT05230381
Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection No drug interventions prevention Not Available recruiting NCT05278208
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors treatment 1 / 2 recruiting NCT04113408
MEningioma Detection Using Non Contrast MRI TecHniquEs No drug interventions Not Available Not Available recruiting NCT06278103
Correlation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas (MethylRH-M) No drug interventions Not Available Not Available enrolling_by_invitation NCT05821790
Role of the Tumor Microenvironment in Aggressive Meningiomas No drug interventions Not Available Not Available not_yet_recruiting NCT04087902
Long-Term Longitudinal QoL in Patients Undergoing EEA No drug interventions Not Available Not Available recruiting NCT01941602
A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery Not Available Not Available completed NCT00589784
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma treatment 2 completed NCT04367779
Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. No drug interventions Not Available Not Available recruiting